NDC 83854-014-01 - ROPIVACAINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83854-014
- Requested NDC
- 83854-014-01
- Package NDCs from labels
- 83854-014-01, 83854-014-06, 83854-014-10, 83854-014-05, 83854-014-02, 83854-014-25, 83854-014-26
- Manufacturer
- Anthea Pharma Private Limited
- Effective date
- 2025-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE - Anthea Pharma Private Limited | Anthea Pharma Private Limited | 2025-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83854-014-01 | ROPIVACAINE HYDROCHLORIDE | 30 mL in 1 VIAL | INJECTION, SOLUTION | 30 | 8 | |
| 83854-014-02 | ROPIVACAINE HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 8 | |
| 83854-014-05 | ROPIVACAINE HYDROCHLORIDE | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 8 | |
| 83854-014-06 | ROPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 8 | |
| 83854-014-10 | ROPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 | |
| 83854-014-25 | ROPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 8 | |
| 83854-014-26 | ROPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.